linoleic acid
Linoleic acid is a polyunsaturated omega-6 fatty acid. Linoleic acid has been found to have antibacterial activity, particularly in inhibiting the growth of Gram-positive bacterial species.
Classification
antibacterial free fatty acidsARO:3003956
- antibacterial free fatty acids
ARO:3003956
Chemical structure
| Molecular formula | C18H32O2 |
|---|---|
| Charge | 0 |
| Average mass | 280.452 Da |
| Monoisotopic mass | 280.24023 Da |
| Source | ChEBI |
| InChIKey | OYHQOLUKZRVURQ-HZJYTTRNSA-N |
CCCCC/C=C\C/C=C\CCCCCCCC(=O)O
InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-
Also called
- Linoleate
- Linolic acid
- Telfairic acid
Cross-references
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3003959 |
linoleic acid | antibioticmech:aro-36bd42c165 |
2026-08-30 |
Molecular targets
bacterial cytoplasmic membrane MEMBRANE ATTACKED_COMPONENT
Staphylococcus aureus NCBITaxon:1280; strain NCTC 8325
Mechanism summary
- Mode of action
- MEMBRANE_DISRUPTION host shared target
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Staphylococcus aureus NCBITaxon:1280 | ACTIVE | — | — | Growth inhibition accompanied by a bacterial-membrane permeability increase; the abstract does not report an MIC. | NCTC 8325 | — | EvidencePage data (JSON.gz) |
Resistance mechanisms
ANTIBIOTIC_EFFLUX 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| farAB | ARO:3003960 | — |
Record-level evidence
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED
Verified the exact ChEBI structure and ARO antibacterial classification; added a strain-scoped membrane-disruption mechanism, molecular component, and qualitative activity observation; checked primary support for the existing farAB resistance assertion.